This report summarises a December 2018 meeting organised by the Hepatitis C Coalition to discuss hepatitis C and BBVs in prison. The report covers discussion points including the need for better implementation of opt-out testing, reducing points of attrition along the care pathway, tackling stigma and developing stronger links with community services.
R&D, Competition and Diffusion of Innovation in the EU: The Case of Hepatitis C

Download
This research paper assesses the impact of (i) incentives for R&D based on providing Intellectual Property (IP) rights protection, (ii) market competition and (iii) other factors including healthcare policies on access to direct acting antivirals (DAA) for hepatitis C in Europe.